MDxHealth to Present First Quarter 2023 Financial Results on May 15
01 Maio 2023 - 5:00PM
MDxHealth to Present First Quarter 2023 Financial Results on May 15
NEWS RELEASE 1
MAY
2023,
4PM ET /
22:00 CET
MDxHealth
to Present First Quarter 2023
Financial Results on May 15
Company to Host Conference Call
with Live Q&A, May
15, 2023
at
4:30pm
ET/
22:30
CET
IRVINE, CA, and HERSTAL,
BELGIUM – May 1, 2023 – MDxHealth SA (NASDAQ/Euronext:
MDXH), a commercial-stage precision diagnostics company, today
announced it will release its financial results for the first
quarter ended March 31, 2023, after market close on Monday, May 15,
2023.
|
Title: |
MDxHealth Presents First Quarter 2023 Financial Results Conference
Call and Webcast |
|
Speakers: |
Michael K. McGarrity, Chief Executive OfficerRon Kalfus, Chief
Financial Officer |
|
Date: |
May 15, 2023 |
|
Time: |
4:30pm ET/ 22:30 CET |
|
Conference Call Dial-in
Details: |
United States: 1-877-407-9716Belgium: 0800 73904The Netherlands:
0800 023 4340United Kingdom: 0800 756 3429 |
|
Conference ID: |
13738494 |
|
Webcast: |
https://viavid.webcasts.com/starthere.jsp?ei=1612703&tp_key=c5b907adf5 |
The webcast should be accessed 15 minutes prior to the
conference call start time. A replay of the webcast will be
available following the conclusion of the live call and will be
accessible on the Company’s website.
About MDxHealthmdxhealth is a commercial-stage
precision diagnostics company that provides actionable molecular
information to personalize patient diagnosis and treatment. The
Company’s tests are based on proprietary genomic, epigenetic
(methylation) and other molecular technologies and assist
physicians with the diagnosis and prognosis of urologic cancers and
other urologic diseases. The Company’s U.S. headquarters and
laboratory operations are in Irvine, California, with additional
laboratory operations in Plano, Texas. European headquarters are in
Herstal, Belgium, with laboratory operations in Nijmegen, The
Netherlands. For more information,
visit mdxhealth.com and follow us on social media
at: twitter.com/mdxhealth, facebook.com/mdxhealth and linkedin.com/company/mdxhealth.
For more information:
|
MDxHealth info@mdxhealth.com |
|
| LifeSci
Advisors (IR & PR)US: +1 949 271
9223ir@mdxhealth.com |
|
NOTE: The mdxhealth logo,
mdxhealth, Confirm mdx, Select mdx, Resolve mdx, Genomic Prostate
Score, GPS and Monitor mdx are trademarks or registered trademarks
of MDxHealth SA. All other trademarks and service marks are the
property of their respective owners.
- MDXH 1Q23 Earnings Save the Date
Mdxhealth (LSE:0O8G)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024
Mdxhealth (LSE:0O8G)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024
